Back to Search
SCOTT ZAMVIL, MD
MD
Neurology Physician
NPI: 1720139348IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
G66283(CA)
CMS Specialties
PrimaryNEUROLOGY
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1988
Research & Publications (20)
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis.
PMID 12797954·Neuron·2003
6-review
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis.
PMID 19255448·Proc Natl Acad Sci U S A·2009
7-preclinical
Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
PMID 19667224·Arch Neurol·2009
5-case
Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.
PMID 19022862·Brain·2009
8-other
Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
PMID 18687587·Int Immunol·2008
7-preclinical
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.
PMID 18852339·Arch Neurol·2008
2-rct
Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.
PMID 18535577·Nat Med·2008
8-other
Disease-modifying agents for multiple sclerosis: recent advances and future prospects.
PMID 19016573·Drugs·2008
6-review
Mechanism of action of glatiramer acetate in treatment of multiple sclerosis.
PMID 17920545·Neurotherapeutics·2007
6-review
Statins--treatment option for central nervous system autoimmune disease?
PMID 17920550·Neurotherapeutics·2007
6-review
Simvastatin regulates oligodendroglial process dynamics and survival.
PMID 17078030·Glia·2007
7-preclinical
Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis.
PMID 17306890·J Neuroimmunol·2007
8-other
Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice.
PMID 17495621·Curr Opin Neurol·2007
6-review
Type II monocytes modulate T cell-mediated central nervous system autoimmune disease.
PMID 17676050·Nat Med·2007
7-preclinical
The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologists.
PMID 18090713·Neurologist·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 350 PARNASSUS AVE
SAN FRANCISCO, CA 94143 - Phone
- (415) 514-1684
Quick Facts
- NPI
- 1720139348
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile